Newedge Advisors, LLC’s Abbvie Inc Position
Does Newedge Advisors, LLC own Abbvie Inc (ABBV)? Yes — 632.1K shares worth $137M (+0.50% of its 13F portfolio) as of Q2 2026, up from 626.5K shares the prior filed quarter.
Position Value
$137M
Q2 2026
Shares
632.1K
% of Portfolio
+0.50%
Quarters Held
30
currently held
Position History ABBV
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q2 2026 | 632.1K | $137M | +0.50% |
| Q4 2025 | 626.5K | $143M | +0.52% |
| Q3 2025 | 581.2K | $135M | +0.61% |
| Q2 2025 | 555.6K | $103M | +0.53% |
| Q1 2025 | 510.0K | $107M | +0.63% |
| Q4 2024 | 497.3K | $88M | +0.53% |
| Q3 2024 | 452.9K | $89M | +0.58% |
| Q2 2024 | 441.9K | $76M | +0.55% |
| Q1 2024 | 390.0K | $71M | +0.62% |
| Q4 2023 | 388.5K | $61M | +0.58% |
| Q3 2023 | 385.4K | $57M | +0.63% |
| Q2 2023 | 335.5K | $45M | +0.51% |
| Q1 2023 | 125.2K | $20M | +0.25% |
| Q4 2022 | 125.6K | $11M | +0.30% |
| Q3 2022 | 119.7K | $16M | +0.26% |
| Q2 2022 | 118.0K | $18M | +0.30% |
| Q1 2022 | 121.5K | $20M | +0.32% |
| Q4 2021 | 101.4K | $14M | +0.21% |
| Q3 2021 | 55.5K | $6M | +0.15% |
| Q2 2021 | 46.2K | $5M | +0.14% |
| Q1 2021 | 40.3K | $4M | +0.13% |
| Q4 2020 | 38.1K | $4M | +0.13% |
| Q3 2020 | 40.4K | $4M | +0.12% |
| Q2 2020 | 36.2K | $4M | +0.14% |
| Q1 2020 | 30.0K | $2M | +0.11% |
| Q4 2019 | 39.8K | $4M | +0.14% |
| Q3 2019 | 38.2K | $3M | +0.13% |
| Q2 2019 | 35.2K | $3M | +0.16% |
| Q1 2019 | 36.5K | $3M | +0.19% |
| Q4 2018 | 47.8K | $4M | +0.28% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Newedge Advisors, LLC’s full portfolio or all institutional holders of ABBV.